Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure

E-ISSN： 1875-6174|2|4|287-294

ISSN： 1568-0169

Source： Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol.2, Iss.4, 2004-10, pp. : 287-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta‐Analysis and Systematic Review

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 10, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade

By Funder John W

Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. : 535-541

Future Medicine

Access to resources Recommend Favorite

Cardiac Remodeling as Therapeutic Target: Treating Heart Failure with Cardiac Support Devices

By Mann Douglas

Heart Failure Reviews, Vol. 10, Iss. 2, 2005-06 ,pp. : 93-94

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism

Current Hypertension Reviews, Vol. 13, Iss. 1, 2017-06 ,pp. : 46-56

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Subcellular Remodeling in Cardiac Dysfunction due to Congestive Heart Failure

Medical Principles and Practice, Vol. 16, Iss. 2, 2007-02 ,pp. : 81-89

Karger

Access to resources Recommend Favorite